Statutory guidance

MHRA fees

Fees payable to the MHRA for 2020 to 2021

Documents

MHRA fees definitions

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Periodic fees terminology

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Payment easements

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Fees extracts

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Fees for new suppliers of defined simple active pharmaceutical ingredients (APIs)

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The document attached lists MHRA fees for 2020 to 2021. It incorporates new EU Exit fees which come into force on 1 January 2021.

For further information on EU Exit fees see The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020.

MHRA’s fees changed on April 1 2016. MHRA fees for 2020 to 2021 are remaining the same as 2019 to 2020.

Published 18 December 2014
Last updated 31 December 2020 + show all updates
  1. Added new information on fees following the end of the transition period. This includes new sections on orphan marketing products, Pharmacovigilance (PV) Safety Reviews, pre-assessment (rolling review) fees, PMF and Vaccine Antigen Master File certification.

  2. Amended text under 'Current MHRA fees' guidance. Section '13. Inspection: fees'.

  3. We have updated the years references to the periodic fees

  4. Update to confirm fee levels for 2020 to 2021 are remaining the same as 2019 to 2020

  5. Minor amendment to the explanation of the Office Based Inspection Fee to include information that was left out by mistake.

  6. Information about 2017/18 fees added to the page.

  7. MHRA's fees changed on April 1 2016.

  8. MHRA's fees change on April 1 2016. Uploaded a PDF of the changed fees.

  9. First published.